These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35766333)

  • 21. Mutations in the
    Zou S; Ye J; Hu S; Wei Y; Xu J
    Int J Gen Med; 2022; 15():19-31. PubMed ID: 35018111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients.
    Shuwen H; Xi Y; Miao D; Jiamin X; Jing Z; Weili G
    Dis Markers; 2020; 2020():9369341. PubMed ID: 32626543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E2F, HSF2, and miR-26 in thyroid carcinoma: bioinformatic analysis of RNA-sequencing data.
    Lu JC; Zhang YP
    Genet Mol Res; 2016 Mar; 15(1):15017576. PubMed ID: 26985959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma.
    Zhang S; Chen S; Wang Y; Zhan Y; Li J; Nong X; Gao B
    Front Genet; 2021; 12():744304. PubMed ID: 34976004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Key Pathways and Genes Downstream of Insulin-Like Growth Factor 1 in Thyroid Carcinoma.
    Wang J; Wu L; Lu W; Zhang H; Wu Y
    Genet Test Mol Biomarkers; 2022 Nov; 26(11):522-531. PubMed ID: 36440844
    [No Abstract]   [Full Text] [Related]  

  • 26. DNAJB11 predicts a poor prognosis and is associated with immune infiltration in thyroid carcinoma: a bioinformatics analysis.
    Sun R; Yang L; Wang Y; Zhang Y; Ke J; Zhao D
    J Int Med Res; 2021 Nov; 49(11):3000605211053722. PubMed ID: 34727750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
    Li C; Liu T; Liu Y; Zhang J; Zuo D
    J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Identification of Three Key Genes Related to Stemness in Thyroid Carcinoma through Comprehensive Analysis.
    Zhang T; Yan C; Ye Z; Yin X; Jiang TA
    Comb Chem High Throughput Screen; 2021; 24(3):423-432. PubMed ID: 32767928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
    Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
    J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification an innovative classification and nomogram for predicting the prognosis of thyroid carcinoma patients and providing therapeutic schedules.
    Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14817-14831. PubMed ID: 37596371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PCDH8 is a novel prognostic biomarker in thyroid cancer and promotes cell proliferation and viability.
    Yang R; Yang N; Yin P; Xue Z; Sun F; Fan R; Liang J; Lv X; Wu S; Sun L
    Funct Integr Genomics; 2024 Feb; 24(2):35. PubMed ID: 38368303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma.
    Sahin Y
    Clin Exp Med; 2023 Jul; 23(3):841-851. PubMed ID: 35810257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-Cell RNA Sequencing Revealed a 3-Gene Panel Predicted the Diagnosis and Prognosis of Thyroid Papillary Carcinoma and Associated With Tumor Immune Microenvironment.
    Chen Z; Wang Y; Li D; Le Y; Han Y; Jia L; Yan C; Tian Z; Song W; Li F; Zhao K; He X
    Front Oncol; 2022; 12():862313. PubMed ID: 35359404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment.
    Ma J; Han W; Lu K
    Front Oncol; 2021; 11():711756. PubMed ID: 34490109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation of a glycolysis-related gene signature for predicting metastasis and survival rate in patients with thyroid cancer.
    Wang B; Zhu Y; Zhang X; Wang Z
    Transl Cancer Res; 2023 May; 12(5):1100-1111. PubMed ID: 37304543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic analysis of the prognosis and immune infiltration of E2Fs in thyroid carcinoma.
    Fu X; Zhou X; Ji F; He Q; Qiu X
    Front Genet; 2023; 14():1215984. PubMed ID: 37560385
    [No Abstract]   [Full Text] [Related]  

  • 39. Seven Genes Associated With Lymphatic Metastasis in Thyroid Cancer That Is Linked to Tumor Immune Cell Infiltration.
    Wu L; Zhou Y; Guan Y; Xiao R; Cai J; Chen W; Zheng M; Sun K; Chen C; Huang G; Zhang X; Qian Z; Shen S
    Front Oncol; 2021; 11():756246. PubMed ID: 35141140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating the clinical role and prognostic value of genes related to insulin-like growth factor signaling pathway in thyroid cancer.
    Liu J; Miao X; Yao J; Wan Z; Yang X; Tian W
    Aging (Albany NY); 2024 Feb; 16(3):2934-2952. PubMed ID: 38329437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.